David Sinclair Longevity Guru’s Failed Businesses
The article is worth a read if you’re interested and ends in this quote. “Sinclair said he believes that his companies will someday produce life-changing medicines. “Developing medicines that safely and effectively target aging,” he said, “is a difficult endeavor that has turned out to take longer than I expected.” I cited some of the…
Read MoreDangers of Spinal Implants. False Hope and a Cautionary Tale
The cautionary tale of spinal implants for pain. As readers of my book, Radical Resilience know, I used the sad story of a pro Baseball player, Bodie, who had catastrophic results with a spinal stimulator for back pain which almost cost him his life. Again, we don’t want to throw out traditional medical solutions, but…
Read MoreChemical Cocktail to Reverse Aging?
Previous blog posts on David Sinclair here and here. I relied on his research for my book Radical Resilience. A brief video from my YouTube channel on the controversy. Review of new David Sinclair paper, supplements & anti-aging glitz
Read MoreKaeberlein Withdrawing from Academy for Health and Lifespan Research
Matt Kaeberlein withdraws from the Academny for Health and Lifespan Research because of over blow claims by Sinclair After careful consideration, I have renounced my membership in the Academy for Health and Lifespan Research ( @ahlresearc ). I find it deeply distressing that we’ve gotten to a point where dishonesty in science is normalized to…
Read MoreWhen Cancer Should Not Be Called Cancer. Prostate Cancer
Renaming the lowest-risk prostate cancer would cut down on overly aggressive treatment, some doctors say First, Do No Harm. This is often a difficult concept for patients to understand. The drumbeat is always for more and more testing, and earlier and earlier diagnosis. The fact remains, however, that too much information can be as…
Read MoreWho Wants To Live Forever
This article has some of the latest longevity developments for those interested. I wanted to highlight this section on Alzheimer’s research and the role of amyloid. We’ve discussed this before in the blog , and the huge controversy about the approval of the drug Aduhelm in newsletters. This article discusses a new drug that targets…
Read MorePhenylephrine No Better Than Placebo
FDA advisory panel’s declaration paves way for removal of dozens of medicines in the U.S. Your favorite cold medicine for a stuffy nose may soon be unavailable. An advisory panel to the Food and Drug Administration declared Tuesday that an ingredient in widely used oral decongestants doesn’t work, setting the stage for dozens of products…
Read MoreThe Research Scandal at Stanford Is More Common Than You Think
“This is a major issue, one that extends well beyond one man and his career. Absent public scrutiny, journals have been consistently slow to act on allegations of research falsification. In a field dependent on good faith cooperation, in which each contribution necessarily builds on the science that came before it, the consequences can compound…
Read MoreOpiates No Good For Back and Neck Pain
Opiates No Good For Back and Neck PainDo No Harm!!! New study from the Lancet shows that opiates are no better than placebo for low back and neck pain. My patients know that I’ve never understood the reliance on opioids for these problems since the risk is high and they do nothing to address the…
Read MoreThey Lost Their Legs. Doctors and Health Care Giants Profited.
The perverse incentives that arise in our medical system can have horrible consequences. First do no harm. Or another hazard, Science Says No, Doctor Says Yes.As the article says. But more than a decade of medical research has shown that the vast majority of people with peripheral artery disease have mild or no symptoms and…
Read More